Skip to Content

Clinical Trial Details

Chemotherapy Before Prostate Removal

Randomized Phase III Study of Neo-adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy Versus Immediate Radical Prostatectomy in Patients with High-risk, Clinically Localized Prostate Cancer

Objective

The study will compare the effects of hormone therapy and chemotherapy before surgery compared to just surgery alone.

IRB Protocol Number
CALGB 90203
Principal Investigator(s)
Charles Catcher, MD

Clinical Trial Categories

  • Prostate Cancer
Sponsor(s)
National Cancer Institute
Contact
Margaret White, RN OCN, CC at 603-232-8908
How to Participate

Inclusion Criteria:

  • Men who have prostate cancer and are at risk of the cancer returning after surgery to remove their prostate are eligible for this study.

Location

  • Payson Center for Cancer Care
    250 Pleasant Street
    Concord, NH 03301
    Main: 603-230-6000